● Recruiting

Observational, Passive Surveillance Program to Collect Information on Women and Their Offspring Exposed to MenQuadfi® During Pregnancy, in United States (US)

Condition: Meningococcal Infection · Sponsor: Sanofi Pasteur, a Sanofi Company

PhaseN/A

Planned participants50

Who can joinAll sexes, N/A to no upper limit

Healthy volunteersYes

About this study

Primary Objective: To assess maternal, obstetrical, pregnancy, and neonatal and infant outcomes among women vaccinated with MenQuadfi® during pregnancy or in the 30 days preceding their Last Menstrual Period (LMP).

This description comes directly from the study's public registry record.

Talk to the study team

Trial Transparency email recommended (Toll free number for US & Canada) · 800-633-1610 · Contact-Us@sanofi.com

Always discuss trial participation with your own doctor first.

Locations (1)

Pennsylvania Locations

Swiftwater, Pennsylvania, United States

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04843111